Potential reasons for unresponsiveness to anti-PD1 immunotherapy in young patients with advanced melanoma

The impact of age on the clinical benefit of anti-PD1 immunotherapy in advanced melanoma patients has been evolving recently. Due to a reduced immune function in elderly patients, young patients with a robust immune system are theoretically expected to benefit more from the treatment approach. Howev...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Machiraju, Devayani (VerfasserIn) , Schäfer, Sarah (VerfasserIn) , Hassel, Jessica C. (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 30 November 2021
In: Life
Year: 2021, Jahrgang: 11, Heft: 12, Pages: 1-17
ISSN:2075-1729
DOI:10.3390/life11121318
Online-Zugang:Verlag, kostenfrei, Volltext: https://doi.org/10.3390/life11121318
Verlag, kostenfrei, Volltext: https://www.mdpi.com/2075-1729/11/12/1318
Volltext
Verfasserangaben:Devayani Machiraju, Sarah Schäfer, Jessica C. Hassel

MARC

LEADER 00000caa a2200000 c 4500
001 179469854X
003 DE-627
005 20220820142144.0
007 cr uuu---uuuuu
008 220304s2021 xx |||||o 00| ||eng c
024 7 |a 10.3390/life11121318  |2 doi 
035 |a (DE-627)179469854X 
035 |a (DE-599)KXP179469854X 
035 |a (OCoLC)1341445770 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Machiraju, Devayani  |e VerfasserIn  |0 (DE-588)1165195224  |0 (DE-627)1029355924  |0 (DE-576)510306586  |4 aut 
245 1 0 |a Potential reasons for unresponsiveness to anti-PD1 immunotherapy in young patients with advanced melanoma  |c Devayani Machiraju, Sarah Schäfer, Jessica C. Hassel 
264 1 |c 30 November 2021 
300 |a 17 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 04.03.2022 
520 |a The impact of age on the clinical benefit of anti-PD1 immunotherapy in advanced melanoma patients has been evolving recently. Due to a reduced immune function in elderly patients, young patients with a robust immune system are theoretically expected to benefit more from the treatment approach. However, in contrast to this hypothesis, recent studies in patients with metastatic melanoma have demonstrated that immunotherapy, especially with anti-PD1 treatment, is less effective in patients below 65 years, on average, with significantly lower responses and reduced overall survival compared to patients above 65 years of age. Besides, data on young patients are even more sparse. Hence, in this review, we will focus on age-dependent differences in the previously described resistance mechanisms to the treatment and discuss the development of potential combination treatment strategies for enhancing the anti-tumor efficacy of anti-PD1 or PDL1 treatment in young melanoma patients. 
650 4 |a age 
650 4 |a gender 
650 4 |a gut microbiome 
650 4 |a immunotherapy 
650 4 |a melanoma 
650 4 |a radiation 
650 4 |a stress 
650 4 |a Tregs 
650 4 |a tumor antigenicity 
650 4 |a vaccination 
700 1 |a Schäfer, Sarah  |e VerfasserIn  |0 (DE-588)1219100552  |0 (DE-627)1734834471  |4 aut 
700 1 |a Hassel, Jessica C.  |d 1975-  |e VerfasserIn  |0 (DE-588)129790702  |0 (DE-627)480399069  |0 (DE-576)29783715X  |4 aut 
773 0 8 |i Enthalten in  |t Life  |d Basel : MDPI, 2011  |g 11(2021), 12, Artikel-ID 1318, Seite 1-17  |h Online-Ressource  |w (DE-627)718627156  |w (DE-600)2662250-6  |w (DE-576)365413682  |x 2075-1729  |7 nnas  |a Potential reasons for unresponsiveness to anti-PD1 immunotherapy in young patients with advanced melanoma 
773 1 8 |g volume:11  |g year:2021  |g number:12  |g elocationid:1318  |g pages:1-17  |g extent:17  |a Potential reasons for unresponsiveness to anti-PD1 immunotherapy in young patients with advanced melanoma 
856 4 0 |u https://doi.org/10.3390/life11121318  |x Verlag  |x Resolving-System  |z kostenfrei  |3 Volltext 
856 4 0 |u https://www.mdpi.com/2075-1729/11/12/1318  |x Verlag  |z kostenfrei  |3 Volltext 
951 |a AR 
992 |a 20220304 
993 |a Article 
994 |a 2021 
998 |g 129790702  |a Hassel, Jessica C.  |m 129790702:Hassel, Jessica C.  |d 910000  |d 911300  |d 50000  |e 910000PH129790702  |e 911300PH129790702  |e 50000PH129790702  |k 0/910000/  |k 1/910000/911300/  |k 0/50000/  |p 3  |y j 
998 |g 1219100552  |a Schäfer, Sarah  |m 1219100552:Schäfer, Sarah  |d 910000  |d 911300  |e 910000PS1219100552  |e 911300PS1219100552  |k 0/910000/  |k 1/910000/911300/  |p 2 
998 |g 1165195224  |a Machiraju, Devayani  |m 1165195224:Machiraju, Devayani  |d 910000  |d 911300  |e 910000PM1165195224  |e 911300PM1165195224  |k 0/910000/  |k 1/910000/911300/  |p 1  |x j 
999 |a KXP-PPN179469854X  |e 4078559395 
BIB |a Y 
SER |a journal 
JSO |a {"title":[{"title_sort":"Potential reasons for unresponsiveness to anti-PD1 immunotherapy in young patients with advanced melanoma","title":"Potential reasons for unresponsiveness to anti-PD1 immunotherapy in young patients with advanced melanoma"}],"note":["Gesehen am 04.03.2022"],"type":{"media":"Online-Ressource","bibl":"article-journal"},"language":["eng"],"relHost":[{"part":{"volume":"11","year":"2021","issue":"12","text":"11(2021), 12, Artikel-ID 1318, Seite 1-17","extent":"17","pages":"1-17"},"title":[{"title_sort":"Life","title":"Life","subtitle":"open access journal"}],"id":{"zdb":["2662250-6"],"issn":["2075-1729"],"eki":["718627156"]},"note":["Gesehen am 23.06.20"],"type":{"media":"Online-Ressource","bibl":"periodical"},"language":["eng"],"pubHistory":["1.2011 -"],"origin":[{"dateIssuedKey":"2011","publisherPlace":"Basel","dateIssuedDisp":"2011-","publisher":"MDPI"}],"disp":"Potential reasons for unresponsiveness to anti-PD1 immunotherapy in young patients with advanced melanomaLife","recId":"718627156","physDesc":[{"extent":"Online-Ressource"}]}],"person":[{"display":"Machiraju, Devayani","family":"Machiraju","given":"Devayani","role":"aut"},{"display":"Schäfer, Sarah","role":"aut","given":"Sarah","family":"Schäfer"},{"family":"Hassel","role":"aut","given":"Jessica C.","display":"Hassel, Jessica C."}],"origin":[{"dateIssuedDisp":"30 November 2021","dateIssuedKey":"2021"}],"recId":"179469854X","physDesc":[{"extent":"17 S."}],"id":{"doi":["10.3390/life11121318"],"eki":["179469854X"]},"name":{"displayForm":["Devayani Machiraju, Sarah Schäfer, Jessica C. Hassel"]}} 
SRT |a MACHIRAJUDPOTENTIALR3020